Xenon Pharmaceuticals XENE Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's short-term investments?
- Xenon Pharmaceuticals (XENE) reported short-term investments of $548.88M in Q1 2026.
- How has Xenon Pharmaceuticals's short-term investments changed year-over-year?
- Xenon Pharmaceuticals's short-term investments increased by 26.8% year-over-year, from $432.97M to $548.88M.
- What is the long-term trend for Xenon Pharmaceuticals's short-term investments?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's short-term investments has grown at a 21.5% compound annual growth rate (CAGR), from $131.99M to $349.72M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.